1887

Abstract

Purpose. Oesophageal squamous cell carcinoma (ESCC) is the dominant type of oesophageal cancer among the East Asian population. The role of ESCC tissue bacteria in neoplastic progression has not been fully elucidated. Our goal was to uncover different bacterial communities in pathological staging grouping of ESCC and to identify microorganisms that could predict the likelihood of prognosis.

Methodology. Tissue samples were obtained from 45 patients and assessed using 16S ribosomal RNA gene sequencing. Significant bacteria were selected to perform survival analysis and evaluate prognostic biomarker.

Results/Key findings. We observed variations in the abundance of oesophageal flora among different pathological characteristics of ESCC. Phylum Bacteroidetes, Firmicutes and Spirochaetes showed significantly higher relative abundances among N+ (positive lymph node) patients when compared to N– (negative lymph node) controls, whereas Proteobacteria showed lower abundances in N+ patients. Both genera Prevotella and Treponema were more abundant in the N+ group. In regard to T stage, the abundance of only Streptococcus in T3–4 was significantly higher than that in T1–2, while the other genera showed no significance. On multivariable analysis adjusted for the effects of standard clinicopathological features, combined Streptococcus and Prevotella abundance retained its association with unfavourable survival (hazard ratio, 6.094; 95 % confidence interval, 1.072–34.646; P=0.042), suggesting that this may be an independent prognostic indicator for ESCC.

Conclusion. Combined Streptococcus and Prevotella abundance is regarded as an independent species prognostic biomarker in ESCC patients.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000754
2018-06-20
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/8/1058.html?itemId=/content/journal/jmm/10.1099/jmm.0.000754&mimeType=html&fmt=ahah

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65:87–108 [View Article][PubMed]
    [Google Scholar]
  2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66:115–132 [View Article][PubMed]
    [Google Scholar]
  3. Winther M, Alsner J, Tramm T, Baeksgaard L, Holtved E et al. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer. Acta Oncol 2015; 54:1582–1591 [View Article][PubMed]
    [Google Scholar]
  4. Burke CM, Darling AE. A method for high precision sequencing of near full-length 16S rRNA genes on an Illumina MiSeq. PeerJ 2016; 4:e2492 [View Article][PubMed]
    [Google Scholar]
  5. Reimers LL, Mehta SD, Massad LS, Burk RD, Xie X et al. The cervicovaginal microbiota and its associations with human papillomavirus detection in HIV-infected and HIV-uninfected women. J Infect Dis 2016; 214:1361–1369 [View Article][PubMed]
    [Google Scholar]
  6. Verstraelen H, Vilchez-Vargas R, Desimpel F, Jauregui R, Vankeirsbilck N et al. Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ 2016; 4:e1602 [View Article][PubMed]
    [Google Scholar]
  7. Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect 1995; 103:263–268[PubMed]
    [Google Scholar]
  8. International Agency for Research on Cancer WHO Schistosomes, liver flukes and Helicobacter pylori. IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risk Hum 1994; 61:177–240
    [Google Scholar]
  9. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR et al. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005; 3:27 [View Article][PubMed]
    [Google Scholar]
  10. Cover TL, Peek RM. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes 2013; 4:482–493 [View Article][PubMed]
    [Google Scholar]
  11. Guerrero-Preston R, Godoy-Vitorino F, Jedlicka A, Rodríguez-Hilario A, González H et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget 2016; 7:51320–51334 [View Article][PubMed]
    [Google Scholar]
  12. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014; 12:661–672 [View Article][PubMed]
    [Google Scholar]
  13. Li Y, Zhang X, Wang L, Zhou Y, Hassan JS et al. Distribution and gene mutation of enteric flora carrying β-glucuronidase among patients with colorectal cancer. Int J Clin Exp Med 2015; 8:5310–5316[PubMed]
    [Google Scholar]
  14. Thomas AM, Jesus EC, Lopes A, Aguiar S, Begnami MD et al. Tissue-associated bacterial alterations in rectal carcinoma patients revealed by 16S rRNA community profiling. Front Cell Infect Microbiol 2016; 6:179 [View Article][PubMed]
    [Google Scholar]
  15. Nistal E, Fernández-Fernández N, Vivas S, Olcoz JL. Factors determining colorectal cancer: the role of the intestinal microbiota. Front Oncol 2015; 5:220 [View Article][PubMed]
    [Google Scholar]
  16. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207–214 [View Article][PubMed]
    [Google Scholar]
  17. Ye Y, Carlsson G, Agholme MB, Wilson JA, Roos A et al. Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective study. Clin Microbiol Infect 2013; 19:E559E567 [View Article][PubMed]
    [Google Scholar]
  18. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26:2460–2461 [View Article][PubMed]
    [Google Scholar]
  19. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007; 73:5261–5267 [View Article][PubMed]
    [Google Scholar]
  20. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005; 71:8228–8235 [View Article][PubMed]
    [Google Scholar]
  21. Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 2014; 30:3123–3124 [View Article][PubMed]
    [Google Scholar]
  22. Nasrollahzadeh D, Malekzadeh R, Ploner A, Shakeri R, Sotoudeh M et al. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci Rep 2015; 5:8820 [View Article][PubMed]
    [Google Scholar]
  23. Gao XY, Zhi XY, Li HW, Klenk HP, Li WJ. Comparative genomics of the bacterial genus Streptococcus illuminates evolutionary implications of species groups. PLoS One 2014; 9:e101229 [View Article][PubMed]
    [Google Scholar]
  24. Wang K, Lu W, Tu Q, Ge Y, He J et al. Preliminary analysis of salivary microbiome and their potential roles in oral lichen planus. Sci Rep 2016; 6:22943 [View Article][PubMed]
    [Google Scholar]
  25. Di Pilato V, Freschi G, Ringressi MN, Pallecchi L, Rossolini GM et al. The esophageal microbiota in health and disease. Ann N Y Acad Sci 2016; 1381:21–33 [View Article][PubMed]
    [Google Scholar]
  26. Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001; 2001:7–15 [View Article][PubMed]
    [Google Scholar]
  27. Morita E, Narikiyo M, Yano A, Nishimura E, Igaki H et al. Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. Cancer Sci 2003; 94:492–496 [View Article][PubMed]
    [Google Scholar]
  28. Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y et al. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Res 1998; 58:2991–2995[PubMed]
    [Google Scholar]
  29. Schwarz-Linek U, Werner JM, Pickford AR, Gurusiddappa S, Kim JH et al. Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper. Nature 2003; 423:177–181 [View Article][PubMed]
    [Google Scholar]
  30. Cywes C, Wessels MR. Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 2001; 414:648–652 [View Article][PubMed]
    [Google Scholar]
  31. Kawamura Y, Hou XG, Sultana F, Miura H, Ezaki T. Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. Int J Syst Bacteriol 1995; 45:406–408 [View Article][PubMed]
    [Google Scholar]
  32. Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology 2017; 151:363–374 [View Article][PubMed]
    [Google Scholar]
  33. Downes J, Sutcliffe I, Tanner AC, Wade WG. Prevotella marshii sp. nov. and Prevotella baroniae sp. nov., isolated from the human oral cavity. Int J Syst Evol Microbiol 2005; 55:1551–1555 [View Article][PubMed]
    [Google Scholar]
  34. Gürsoy M, Harju I, Matomäki J, Bryk A, Könönen E. Performance of MALDI-TOF MS for identification of oral Prevotella species. Anaerobe 2017; 47:89–93 [View Article][PubMed]
    [Google Scholar]
  35. Fernández-Canigia L, Cejas D, Gutkind G, Radice M. Detection and genetic characterization of β-lactamases in Prevotella intermedia and Prevotella nigrescens isolated from oral cavity infections and peritonsillar abscesses. Anaerobe 2015; 33:8–13 [View Article][PubMed]
    [Google Scholar]
  36. Johansson I, Witkowska E, Kaveh B, Lif Holgerson P, Tanner AC. The microbiome in populations with a low and high prevalence of caries. J Dent Res 2016; 95:80–86 [View Article][PubMed]
    [Google Scholar]
  37. Gosmann C, Anahtar MN, Handley SA, Farcasanu M, Abu-Ali G et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity 2017; 46:29–37 [View Article][PubMed]
    [Google Scholar]
  38. Si J, You HJ, Yu J, Sung J, Ko G. Prevotella as a hub for vaginal microbiota under the influence of host genetics and their association with obesity. Cell Host Microbe 2017; 21:97–105 [View Article][PubMed]
    [Google Scholar]
  39. Anahtar MN, Byrne EH, Doherty KE, Bowman BA, Yamamoto HS et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 2015; 42:965–976 [View Article][PubMed]
    [Google Scholar]
  40. Joseph R, Rajappan S, Nath SG, Paul BJ. Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study. Rheumatol Int 2013; 33:103–109 [View Article][PubMed]
    [Google Scholar]
  41. Scher JU, Bretz WA, Abramson SB. Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?. Curr Opin Rheumatol 2014; 26:424–429 [View Article][PubMed]
    [Google Scholar]
  42. Goh CE, Kopp J, Papapanou PN, Molitor JA, Demmer RT. Association between serum antibodies to periodontal bacteria and rheumatoid factor in the third national health and nutrition examination survey. Arthritis Rheumatol 2016; 68:2384–2393 [View Article][PubMed]
    [Google Scholar]
  43. Dillon SM, Lee EJ, Kotter CV, Austin GL, Dong Z et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol 2014; 7:983–994 [View Article][PubMed]
    [Google Scholar]
  44. Vázquez-Castellanos JF, Serrano-Villar S, Latorre A, Artacho A, Ferrús ML et al. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. Mucosal Immunol 2015; 8:760–772 [View Article][PubMed]
    [Google Scholar]
  45. Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 2013; 35:229–244 [View Article][PubMed]
    [Google Scholar]
  46. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA et al. Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 2006; 95:1568–1575 [View Article][PubMed]
    [Google Scholar]
  47. Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R et al. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer 2014; 110:1930–1935 [View Article][PubMed]
    [Google Scholar]
  48. Lau SK, Fan RY, Lo HW, Ng RH, Wong SS et al. High mortality associated with Catabacter hongkongensis bacteremia. J Clin Microbiol 2012; 50:2239–2243 [View Article][PubMed]
    [Google Scholar]
  49. Moffatt CE, Whitmore SE, Griffen AL, Leys EJ, Lamont RJ. Filifactor alocis interactions with gingival epithelial cells. Mol Oral Microbiol 2011; 26:365–373 [View Article][PubMed]
    [Google Scholar]
  50. Yang L, Lu X, Nossa CW, Francois F, Peek RM et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009; 137:588–597 [View Article][PubMed]
    [Google Scholar]
  51. Nardone G, Compare D. The human gastric microbiota: is it time to rethink the pathogenesis of stomach diseases?. United European Gastroenterol J 2015; 3:255–260 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000754
Loading
/content/journal/jmm/10.1099/jmm.0.000754
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error